References with Melanoma-associated peptides

2021-2022

Landscape of helper and regulatory CD4+ T cells in melanoma
Oliveria et al., Nature (2022) - PMID: 35508657
Products used: PepMix CEF Pool, Human MAGEA-1, Human MAGEA-3, Human MAGE-A4, Human MAGEA-9, Human MAGE-C, Human MAGE-D, Human Melanocyte protein Pmel17 gp100, Huma Tyrosinase, Human PRAME/OIP4, Human NY-ESO
Local delivery of low-dose anti-CTLA-4 to the lymphona basin leads to system T (reg) reduction and effector T cell activation
Van Pul et al., Science Immunology (2022) - PMID: 35857579
Product used: PepMix Human NY-ESO, Human MAGEA-4 & CEFT Pool
Functional T cell reactivity to Melanocyte Antigens is lost during the Progression of Maligant Melanoma, but is restored by Immunization
Przybala et al., Cancers (Basel) (2021) - PMID: 33435427
Products used: PepMix Human Melanocyte protein Pmel 17 gp100, Human NY-ESO, Human Tyrosinase, Human MAGEA-3, & Human Melan-A/MART-1
Identification of Novel of HLA-restricted preferentially expressed Antigen in Melanoma Peptides to facilitate off-the-shelf Tumor-Associated-Antigen-specific T cell therapies
Stanojevic et al., Cytotherapy (2021) - PMID: 33832817
Product used: PepMix Human PRAME/OIP4 & Human Actin
Sulfated Lactosyl Achaeol Archaeosome synergize with Poly(I:C) to enhance the Immunogenicity and Efficacy of a synthetic long Peptide-based Vaccine in a Melanoma Tumor Model
Akache et al., Pharmaceutics (2021) - PMID: 33673382
Product used: Custom Services